文献速递主动脉疾病

编辑推荐——血管内动脉瘤修复术后监测依从性的Meta分析:EVAR监测悖论

Editor's Choice - Meta-Analysis of Compliance with Endovascular Aneurysm Repair Surveillance: The EVAR Surveillance Paradox.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2022-10-20

该系统评价与Meta分析纳入13项队列研究共22762例患者,比较EVAR术后监测依从与不依从患者的生存。不依从比例为43%(95%CI 36-51),两组全因死亡、动脉瘤相关死亡及二次干预风险均无统计学显著差异,证据确定性极低。

要点

  • EVAR术后监测不依从的合并比例为43%(95%CI 36-51)。
  • 不依从与依从患者全因死亡风险无统计学显著差异(HR 1.04,95%CI 0.61-1.77)。
  • 所有结局的证据确定性均为极低。

核心结论

  • 不依从EVAR术后监测的患者生存与依从患者相似。
  • 这些发现对全部EVAR术后患者进行强化监测的价值提出疑问,并强调需要进一步研究个体化或风险调整的监测策略。

研究设计与样本

  • 系统评价与Meta分析,遵循PRISMA指南,检索MEDLINE和Embase(Ovid接口)。
  • 纳入比较EVAR监测依从与不依从患者生存的队列研究,共13项队列研究、22762例患者。
  • 不依从定义为未能参加至少一次EVAR术后随访。
  • 使用Newcastle-Ottawa量表评估偏倚风险,使用GRADE框架评估证据确定性。

主要发现

  • 不依从EVAR监测的合并患者比例为43%(95%CI 36-51)。
  • 不完整随访与完整随访患者在全因死亡风险上无统计学显著差异(HR 1.04,95%CI 0.61-1.77)。
  • 不完整随访与完整随访患者在动脉瘤相关死亡风险上无统计学显著差异(HR 1.80,95%CI 0.85-3.80)。
  • 不完整随访与完整随访患者在二次干预风险上无统计学显著差异(HR 0.66,95%CI 0.31-1.41)。
  • 不依从患者的动脉瘤破裂 odds 较低(OR 0.63,95%CI 0.39-1.01)。

关键数值与推荐

  • 8项研究被判定为高偏倚风险。
  • 效应量采用风险比(HR)或比值比(OR)及95%置信区间(CI),使用逆方差法或Mantel-Haenszel法及随机效应模型计算。

局限性

  • 8项研究被判定为高偏倚风险。
  • 所有结局的证据确定性均为极低。
  • 作者指出这些发现强调需要进一步研究个体化或风险调整的监测策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the survival of patients who attended surveillance after endovascular aneurysm repair (EVAR) with those who were non-compliant. DATA SOURCES: MEDLINE and Embase were searched using the Ovid interface. REVIEW METHODS: A systematic review was conducted complying with the PRISMA guidelines. Eligible studies compared survival in EVAR surveillance compliant patients with non-compliant patients. Non-compliance was defined as failure to attend at least one post-EVAR follow up. The risk of bias was assessed with the Newcastle-Ottawa scale, and the certainty of evidence using the GRADE framework. Primary outcomes were survival and aneurysm related death. Effect measures were the hazard ratio (HR) or odds ratio (OR) and 95% confidence interval (CI) calculated using the inverse variance or Mantel-Haenszel statistical method and random effects models. RESULTS: Thirteen cohort studies with a total of 22 762 patients were included. Eight studies were deemed high risk of bias. The pooled proportion of patients who were non-compliant with EVAR surveillance was 43% (95% CI 36 - 51). No statistically significant difference was found in the hazard of all cause mortality (HR 1.04, 95% CI 0.61 - 1.77), aneurysm related mortality (HR 1.80, 95% CI 0.85-3.80), or secondary intervention (HR 0.66, 95% CI 0.31 - 1.41) between patients who had incomplete and complete follow up after EVAR. The odds of aneurysm rupture were lower in non-compliant patients (OR 0.63, 95% CI 0.39 - 1.01). The certainty of evidence was very low for all outcomes. Subgroup analysis for patients who had no surveillance vs. those with complete surveillance showed no significant difference in all cause mortality (HR 1.10, 95% CI 0.43 - 2.80). CONCLUSION: Patients who were non-compliant with EVAR surveillance had similar survival to those who were compliant. These findings question the value of intense surveillance in all patients post-EVAR and highlight the need for further research on individualised or risk adjusted surveillance.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Antoniou GA, Kontopodis N, Rogers SK, et al. Editor's Choice - Meta-Analysis of Compliance with Endovascular Aneurysm Repair Surveillance: The EVAR Surveillance Paradox. Eur J Vasc Endovasc Surg. 2022. PMID: 36273676. doi:10.1016/j.ejvs.2022.10.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。